Copyright Reports & Markets. All rights reserved.

Global Peficitinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Peficitinib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Peficitinib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Peficitinib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Peficitinib Market Size & Forecast
    • 1.5.1 Global Peficitinib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Peficitinib Sales Quantity (2018-2029)
    • 1.5.3 Global Peficitinib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Cayman Chemical
    • 2.1.1 Cayman Chemical Details
    • 2.1.2 Cayman Chemical Major Business
    • 2.1.3 Cayman Chemical Peficitinib Product and Services
    • 2.1.4 Cayman Chemical Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Cayman Chemical Recent Developments/Updates
  • 2.2 Adooq Bioscience
    • 2.2.1 Adooq Bioscience Details
    • 2.2.2 Adooq Bioscience Major Business
    • 2.2.3 Adooq Bioscience Peficitinib Product and Services
    • 2.2.4 Adooq Bioscience Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Adooq Bioscience Recent Developments/Updates
  • 2.3 BioVision
    • 2.3.1 BioVision Details
    • 2.3.2 BioVision Major Business
    • 2.3.3 BioVision Peficitinib Product and Services
    • 2.3.4 BioVision Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 BioVision Recent Developments/Updates
  • 2.4 Biorbyt
    • 2.4.1 Biorbyt Details
    • 2.4.2 Biorbyt Major Business
    • 2.4.3 Biorbyt Peficitinib Product and Services
    • 2.4.4 Biorbyt Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Biorbyt Recent Developments/Updates
  • 2.5 MyBiosource
    • 2.5.1 MyBiosource Details
    • 2.5.2 MyBiosource Major Business
    • 2.5.3 MyBiosource Peficitinib Product and Services
    • 2.5.4 MyBiosource Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 MyBiosource Recent Developments/Updates
  • 2.6 AbMole
    • 2.6.1 AbMole Details
    • 2.6.2 AbMole Major Business
    • 2.6.3 AbMole Peficitinib Product and Services
    • 2.6.4 AbMole Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 AbMole Recent Developments/Updates
  • 2.7 Taiclone
    • 2.7.1 Taiclone Details
    • 2.7.2 Taiclone Major Business
    • 2.7.3 Taiclone Peficitinib Product and Services
    • 2.7.4 Taiclone Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Taiclone Recent Developments/Updates
  • 2.8 Selleck Chemicals
    • 2.8.1 Selleck Chemicals Details
    • 2.8.2 Selleck Chemicals Major Business
    • 2.8.3 Selleck Chemicals Peficitinib Product and Services
    • 2.8.4 Selleck Chemicals Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Selleck Chemicals Recent Developments/Updates
  • 2.9 BOC Sciences
    • 2.9.1 BOC Sciences Details
    • 2.9.2 BOC Sciences Major Business
    • 2.9.3 BOC Sciences Peficitinib Product and Services
    • 2.9.4 BOC Sciences Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BOC Sciences Recent Developments/Updates
  • 2.10 Wuhan Sun-shine Bio-technology
    • 2.10.1 Wuhan Sun-shine Bio-technology Details
    • 2.10.2 Wuhan Sun-shine Bio-technology Major Business
    • 2.10.3 Wuhan Sun-shine Bio-technology Peficitinib Product and Services
    • 2.10.4 Wuhan Sun-shine Bio-technology Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Wuhan Sun-shine Bio-technology Recent Developments/Updates
  • 2.11 MedKoo Biosciences
    • 2.11.1 MedKoo Biosciences Details
    • 2.11.2 MedKoo Biosciences Major Business
    • 2.11.3 MedKoo Biosciences Peficitinib Product and Services
    • 2.11.4 MedKoo Biosciences Peficitinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 MedKoo Biosciences Recent Developments/Updates

3 Competitive Environment: Peficitinib by Manufacturer

  • 3.1 Global Peficitinib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Peficitinib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Peficitinib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Peficitinib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Peficitinib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Peficitinib Manufacturer Market Share in 2022
  • 3.5 Peficitinib Market: Overall Company Footprint Analysis
    • 3.5.1 Peficitinib Market: Region Footprint
    • 3.5.2 Peficitinib Market: Company Product Type Footprint
    • 3.5.3 Peficitinib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Peficitinib Market Size by Region
    • 4.1.1 Global Peficitinib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Peficitinib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Peficitinib Average Price by Region (2018-2029)
  • 4.2 North America Peficitinib Consumption Value (2018-2029)
  • 4.3 Europe Peficitinib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Peficitinib Consumption Value (2018-2029)
  • 4.5 South America Peficitinib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Peficitinib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Peficitinib Sales Quantity by Type (2018-2029)
  • 5.2 Global Peficitinib Consumption Value by Type (2018-2029)
  • 5.3 Global Peficitinib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Peficitinib Sales Quantity by Application (2018-2029)
  • 6.2 Global Peficitinib Consumption Value by Application (2018-2029)
  • 6.3 Global Peficitinib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Peficitinib Sales Quantity by Type (2018-2029)
  • 7.2 North America Peficitinib Sales Quantity by Application (2018-2029)
  • 7.3 North America Peficitinib Market Size by Country
    • 7.3.1 North America Peficitinib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Peficitinib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Peficitinib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Peficitinib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Peficitinib Market Size by Country
    • 8.3.1 Europe Peficitinib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Peficitinib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Peficitinib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Peficitinib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Peficitinib Market Size by Region
    • 9.3.1 Asia-Pacific Peficitinib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Peficitinib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Peficitinib Sales Quantity by Type (2018-2029)
  • 10.2 South America Peficitinib Sales Quantity by Application (2018-2029)
  • 10.3 South America Peficitinib Market Size by Country
    • 10.3.1 South America Peficitinib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Peficitinib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Peficitinib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Peficitinib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Peficitinib Market Size by Country
    • 11.3.1 Middle East & Africa Peficitinib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Peficitinib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Peficitinib Market Drivers
  • 12.2 Peficitinib Market Restraints
  • 12.3 Peficitinib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Peficitinib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Peficitinib
  • 13.3 Peficitinib Production Process
  • 13.4 Peficitinib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Peficitinib Typical Distributors
  • 14.3 Peficitinib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats.
    According to our (Global Info Research) latest study, the global Peficitinib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Peficitinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Peficitinib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Peficitinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Peficitinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Peficitinib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Peficitinib
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Peficitinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt and MyBiosource, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Peficitinib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Min Purity Less Than 98%
    Min Purity 98%-99%
    Min Purity More Than 99%
    Market segment by Application
    Research
    Medical
    Major players covered
    Cayman Chemical
    Adooq Bioscience
    BioVision
    Biorbyt
    MyBiosource
    AbMole
    Taiclone
    Selleck Chemicals
    BOC Sciences
    Wuhan Sun-shine Bio-technology
    MedKoo Biosciences
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Peficitinib product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Peficitinib, with price, sales, revenue and global market share of Peficitinib from 2018 to 2023.
    Chapter 3, the Peficitinib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Peficitinib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Peficitinib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Peficitinib.
    Chapter 14 and 15, to describe Peficitinib sales channel, distributors, customers, research findings and conclusion.

    Buy now